Antimikrobiella peptider (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antimikrobiella peptider" in Swedish language version.

refsWebsite

Global rank Swedish rank

37doi.org

2^nd place

14^th place

7frontiersin.org

4,679^th place

2,033^rd place

6sciencedirect.com

149^th place

211^th place

5cell.com

2,814^th place

2,182^nd place

4mdpi.com

2,912^th place

1,882^nd place

2tandfonline.com

507^th place

712^th place

2royalsocietypublishing.org

1,993^rd place

1,250^th place

1cpu-bioinfor.org

low place

1aspetjournals.org

6,663^rd place

low place

1wiley.com

222^nd place

202^nd place

1nature.com

234^th place

206^th place

1elsevier.com

610^th place

590^th place

1springer.com

274^th place

271^st place

1oup.com

485^th place

527^th place

1nih.gov

4^th place

17^th place

1worldcat.org

5^th place

9^th place

1futuremedicine.com

low place

1fass.se

low place

112^th place

1dovepress.com

low place

1web.archive.org

1^st place

1asm.org

3,555^th place

2,522^nd place

1jbc.org

4,455^th place

low place

asm.org

iai.asm.org

Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Albertí, S.; Bengoechea, J.A. (2004). ”Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides”. Infection and Immunity 72 (12): sid. 7107–7114. doi:10.1128/IAI.72.12.7107-7114.2004. Arkiverad från originalet den 21 juli 2020. https://web.archive.org/web/20200721224919/https://iai.asm.org/content/72/12/7107. Läst 4 maj 2020.

aspetjournals.org

pharmrev.aspetjournals.org

Yeaman, M.; Yount, N. (2003). ”Mechanisms of Antimicrobial Peptide Action and Resistance”. Pharmacological Reviews 55 (1): sid. 27–55. doi:10.1124/pr.55.1.2. http://pharmrev.aspetjournals.org/content/55/1/27.

cell.com

Zhang, L-J.; Gallo, R. (2016). ”Antimicrobial peptides”. Current Biology 26 (1): sid. R14–R19. doi:10.1016/j.cub.2015.11.017. https://www.cell.com/current-biology/abstract/S0960-9822(15)01409-8.
Hancock, R.; Lehrer, R. (1998). ”Cationic peptides: a new source of antibiotics”. Trends in Biotechnology 16 (2): sid. 82–88. doi:10.1016/S0167-7799(97)01156-6. https://www.cell.com/trends/biotechnology/abstract/S0167-7799(97)01156-6.
Lai, Y.; Gallo, R. (2009). ”AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense”. Trends in Immunology 30 (3): sid. 131–141. doi:10.1016/j.it.2008.12.003. https://www.cell.com/trends/immunology/abstract/S1471-4906(09)00005-2.
Zhang, L.J.; Gallo, R.L. (2016). ”Antimicrobial peptides”. Current Biology 26 (1): sid. 14–19. doi:10.1016/j.cub.2015.11.017. https://www.cell.com/current-biology/abstract/S0960-9822(15)01409-8.
Peschel, A. (2002). ”How do bacteria resist human antimicrobial peptides?”. Trends in Microbiology 10 (4): sid. 179–186. doi:10.1016/S0966-842X(02)02333-8. https://www.cell.com/trends/microbiology/abstract/S0966-842X(02)02333-8.

cpu-bioinfor.org

dramp.cpu-bioinfor.org

”Welcome To Dramp Database”. dramp.cpu-bioinfor.org. http://dramp.cpu-bioinfor.org/. Läst 13 februari 2021.

doi.org

dx.doi.org

Zhang, L-J.; Gallo, R. (2016). ”Antimicrobial peptides”. Current Biology 26 (1): sid. R14–R19. doi:10.1016/j.cub.2015.11.017. https://www.cell.com/current-biology/abstract/S0960-9822(15)01409-8.
Wang, G. (2014). ”Human Antimicrobial Peptides and Proteins”. Pharmaceuticals 7 (5): sid. 545–594. doi:10.3390/ph7050545. https://www.mdpi.com/1424-8247/7/5/545.
Reddy, K.; Yedery, R.; Aranha, C. (2004). ”Antimicrobial peptides: premises and promises”. International Journal of Antimicrobial Agents 24 (6): sid. 536–547. doi:10.1016/j.ijantimicag.2004.09.005. http://www.sciencedirect.com/science/article/pii/S092485790400322X.
Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. https://www.frontiersin.org/articles/10.3389/fcimb.2016.00194/full.
Hancock, R.; Lehrer, R. (1998). ”Cationic peptides: a new source of antibiotics”. Trends in Biotechnology 16 (2): sid. 82–88. doi:10.1016/S0167-7799(97)01156-6. https://www.cell.com/trends/biotechnology/abstract/S0167-7799(97)01156-6.
Yeaman, M.; Yount, N. (2003). ”Mechanisms of Antimicrobial Peptide Action and Resistance”. Pharmacological Reviews 55 (1): sid. 27–55. doi:10.1124/pr.55.1.2. http://pharmrev.aspetjournals.org/content/55/1/27.
Zhu, S. (2008). ”Discovery of six families of fungal defensin-like peptides provides insights into origin and evolution of the CSαβ defensins”. Molecular Immunology 45 (3): sid. 828–838. doi:10.1016/j.molimm.2007.06.354. http://www.sciencedirect.com/science/article/pii/S016158900700418X.
Lai, Y.; Gallo, R. (2009). ”AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense”. Trends in Immunology 30 (3): sid. 131–141. doi:10.1016/j.it.2008.12.003. https://www.cell.com/trends/immunology/abstract/S1471-4906(09)00005-2.
Bastos, P.; Trindade, F.; Costa, J.; Ferreira, R.; Vitorino, R. (2018). ”Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era”. Medicinal Research Reviews 38 (1): sid. 101–146. doi:10.1002/med.21435. https://onlinelibrary.wiley.com/doi/abs/10.1002/med.21435.
Boto, A.; Pérez de la Lastra, J.; González, C. (2018). ”The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs”. Molecules 23 (2): sid. 311. doi:10.3390/molecules23020311. http://www.mdpi.com/1420-3049/23/2/311.
Malmsten, M. (2014). ”Antimicrobial peptides”. Upsala Journal of Medical Sciences 119 (2): sid. 199–204. doi:10.3109/03009734.2014.899278. http://www.tandfonline.com/doi/full/10.3109/03009734.2014.899278.
Zasloff, M. (2002). ”Antimicrobial peptides of multicellular organisms”. Nature 415 (6870): sid. 389–395. doi:10.1038/415389a. https://www.nature.com/articles/415389a.
Reddy, K.V.R.; Yedery, R.D.; Aranha, C. (2004). ”Antimicrobial peptides: premises and promises”. International Journal of Antimicrobial Agents 24 (6): sid. 536–547. doi:10.1016/j.ijantimicag.2004.09.005. https://linkinghub.elsevier.com/retrieve/pii/S092485790400322X.
Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. https://www.frontiersin.org/articles/10.3389/fcimb.2016.00194/full.
Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. http://journal.frontiersin.org/article/10.3389/fcimb.2016.00194/full.
Chung, P.Y.; Khanum, R. (2017). ”Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria”. Journal of Microbiology, Immunology and Infection 50 (4): sid. 405–410. doi:10.1016/j.jmii.2016.12.005. http://www.sciencedirect.com/science/article/pii/S1684118217300804.
Zhang, L.J.; Gallo, R.L. (2016). ”Antimicrobial peptides”. Current Biology 26 (1): sid. 14–19. doi:10.1016/j.cub.2015.11.017. https://www.cell.com/current-biology/abstract/S0960-9822(15)01409-8.
Malmsten, M. (2014). ”Antimicrobial peptides”. Upsala Journal of Medical Sciences 119 (2): sid. 199–204. doi:10.3109/03009734.2014.899278. http://www.tandfonline.com/doi/full/10.3109/03009734.2014.899278.
Mangoni, M.L. (2011). ”Host-defense peptides: from biology to therapeutic strategies”. Cellular and Molecular Life Sciences 68 (13): sid. 2157–2159. doi:10.1007/s00018-011-0709-3. http://link.springer.com/10.1007/s00018-011-0709-3.
Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. http://journal.frontiersin.org/article/10.3389/fcimb.2016.00194/full.
Pachón-Ibáñez, M.E.; Smani, Y.; Pachón, J.; Sánchez-Céspedes, J. (2017). ”Perspectives for clinical use of engineered human host defense antimicrobial peptides”. FEMS Microbiology Reviews 41 (3): sid. 323–342. doi:10.1093/femsre/fux012. https://academic.oup.com/femsre/article/41/3/323/3830264.
Boto, A.; Pérez de la Lastra, J.M.; González, C.C. (2018). ”The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs”. Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry 23 (2). doi:10.3390/molecules23020311. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017364/.
Chung, P.Y.; Khanum, R. (2017). ”Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria”. Journal of Microbiology, Immunology and Infection 50 (4): sid. 405–410. doi:10.1016/j.jmii.2016.12.005. http://www.sciencedirect.com/science/article/pii/S1684118217300804.
”Antimicrobial peptide mimics for improved therapeutic properties” (på engelska). Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (8): sid. 1582–1592. 2009-08-01. doi:10.1016/j.bbamem.2008.10.020. ISSN 0005-2736. https://www.sciencedirect.com/science/article/pii/S0005273608003416. Läst 25 november 2020.
Laverty, G. (2017). ”Peptide nanomaterials as future antimicrobial technologies”. Future Microbiology 13 (1): sid. 5–7. doi:10.2217/fmb-2017-0208. https://www.futuremedicine.com/doi/10.2217/fmb-2017-0208.
Lee, S.; Trinh, T.H.T.; Yoo, M.; Shin, J.; Lee, H.; Kim, J. (2019). ”Self-Assembling Peptides and Their Application in the Treatment of Diseases”. International Journal of Molecular Sciences 20 (23): sid. 5850. doi:10.3390/ijms20235850. https://www.mdpi.com/1422-0067/20/23/5850.
Qiu, F.; Chen, Y.; Tang, C.; Zhao, X.. ”Amphiphilic peptides as novel nanomaterials: design, self-assembly and application”. International Journal of Nanomedicine. doi:10.2147/ijn.s166403. https://www.dovepress.com/amphiphilic-peptides-as-novel-nanomaterials-design-self-assembly-and-a-peer-reviewed-article-IJN. Läst 4 maj 2020.
Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Albertí, S.; Bengoechea, J.A. (2004). ”Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides”. Infection and Immunity 72 (12): sid. 7107–7114. doi:10.1128/IAI.72.12.7107-7114.2004. Arkiverad från originalet den 21 juli 2020. https://web.archive.org/web/20200721224919/https://iai.asm.org/content/72/12/7107. Läst 4 maj 2020.
Parachin, N.S.; Franco, O.L. (2014). ”New edge of antibiotic development: antimicrobial peptides and corresponding resistance”. Frontiers in Microbiology 5. doi:10.3389/fmicb.2014.00147. https://www.frontiersin.org/articles/10.3389/fmicb.2014.00147/full.
Peschel, A. (2002). ”How do bacteria resist human antimicrobial peptides?”. Trends in Microbiology 10 (4): sid. 179–186. doi:10.1016/S0966-842X(02)02333-8. https://www.cell.com/trends/microbiology/abstract/S0966-842X(02)02333-8.
Gaspar, D.; Veiga, A.S.; Castanho, M.A.R.B. (2013). ”From antimicrobial to anticancer peptides. A review”. Frontiers in Microbiology 4. doi:10.3389/fmicb.2013.00294. https://www.frontiersin.org/articles/10.3389/fmicb.2013.00294/full.
Joo, H.S.; Fu, C.I.; Otto, M. (2016). ”Bacterial strategies of resistance to antimicrobial peptides”. Philosophical Transactions of the Royal Society B: Biological Sciences 371 (1695): sid. 20150292. doi:10.1098/rstb.2015.0292. https://royalsocietypublishing.org/doi/10.1098/rstb.2015.0292.
Groisman, E.A. (1994). ”How bacteria resist killing by host-defense peptides”. Trends in Microbiology 2 (11): sid. 444–449. doi:10.1016/0966-842X(94)90802-8. http://www.sciencedirect.com/science/article/pii/0966842X94908028.
Peschel, A.; Otto, M.; Jack, R.W.; Kalbacher, H.; Jung, G.; Götz, F. (1999). ”Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides”. Journal of Biological Chemistry 274 (13): sid. 8405–8410. doi:10.1074/jbc.274.13.8405. http://www.jbc.org/content/274/13/8405.
Alvarez-Ortega, C.; Olivares, J.; Martinez, J.L. (2013). ”RND multidrug efflux pumps: what are they good for?”. Frontiers in Microbiology 4. doi:10.3389/fmicb.2013.00007. https://www.frontiersin.org/articles/10.3389/fmicb.2013.00007/full.
Bahar, A.A.; Ren, D. (2013). ”Antimicrobial Peptides”. Pharmaceuticals 6 (12): sid. 1543–1575. doi:10.3390/ph6121543. https://www.mdpi.com/1424-8247/6/12/1543.
Habets, M.G.; Brockhurst, M.A. (2012). ”Therapeutic antimicrobial peptides may compromise natural immunity”. Biology Letters 8 (3): sid. 416–418. doi:10.1098/rsbl.2011.1203. https://royalsocietypublishing.org/doi/10.1098/rsbl.2011.1203.

dovepress.com

Qiu, F.; Chen, Y.; Tang, C.; Zhao, X.. ”Amphiphilic peptides as novel nanomaterials: design, self-assembly and application”. International Journal of Nanomedicine. doi:10.2147/ijn.s166403. https://www.dovepress.com/amphiphilic-peptides-as-novel-nanomaterials-design-self-assembly-and-a-peer-reviewed-article-IJN. Läst 4 maj 2020.

elsevier.com

linkinghub.elsevier.com

Reddy, K.V.R.; Yedery, R.D.; Aranha, C. (2004). ”Antimicrobial peptides: premises and promises”. International Journal of Antimicrobial Agents 24 (6): sid. 536–547. doi:10.1016/j.ijantimicag.2004.09.005. https://linkinghub.elsevier.com/retrieve/pii/S092485790400322X.

fass.se

FASS (2020). ”Captopril Mylan”. https://www.fass.se/LIF/product?userType=0&nplId=19940629000051. Läst 4 maj 2020.

frontiersin.org

Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. https://www.frontiersin.org/articles/10.3389/fcimb.2016.00194/full.
Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. https://www.frontiersin.org/articles/10.3389/fcimb.2016.00194/full.
Parachin, N.S.; Franco, O.L. (2014). ”New edge of antibiotic development: antimicrobial peptides and corresponding resistance”. Frontiers in Microbiology 5. doi:10.3389/fmicb.2014.00147. https://www.frontiersin.org/articles/10.3389/fmicb.2014.00147/full.
Gaspar, D.; Veiga, A.S.; Castanho, M.A.R.B. (2013). ”From antimicrobial to anticancer peptides. A review”. Frontiers in Microbiology 4. doi:10.3389/fmicb.2013.00294. https://www.frontiersin.org/articles/10.3389/fmicb.2013.00294/full.
Alvarez-Ortega, C.; Olivares, J.; Martinez, J.L. (2013). ”RND multidrug efflux pumps: what are they good for?”. Frontiers in Microbiology 4. doi:10.3389/fmicb.2013.00007. https://www.frontiersin.org/articles/10.3389/fmicb.2013.00007/full.

journal.frontiersin.org

Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. http://journal.frontiersin.org/article/10.3389/fcimb.2016.00194/full.
Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. (2016). ”Antimicrobial Peptides: An Emerging Category of Therapeutic Agents”. Frontiers in Cellular and Infection Microbiology 6. doi:10.3389/fcimb.2016.00194. http://journal.frontiersin.org/article/10.3389/fcimb.2016.00194/full.

futuremedicine.com

Laverty, G. (2017). ”Peptide nanomaterials as future antimicrobial technologies”. Future Microbiology 13 (1): sid. 5–7. doi:10.2217/fmb-2017-0208. https://www.futuremedicine.com/doi/10.2217/fmb-2017-0208.

jbc.org

Peschel, A.; Otto, M.; Jack, R.W.; Kalbacher, H.; Jung, G.; Götz, F. (1999). ”Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides”. Journal of Biological Chemistry 274 (13): sid. 8405–8410. doi:10.1074/jbc.274.13.8405. http://www.jbc.org/content/274/13/8405.

mdpi.com

Wang, G. (2014). ”Human Antimicrobial Peptides and Proteins”. Pharmaceuticals 7 (5): sid. 545–594. doi:10.3390/ph7050545. https://www.mdpi.com/1424-8247/7/5/545.
Boto, A.; Pérez de la Lastra, J.; González, C. (2018). ”The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs”. Molecules 23 (2): sid. 311. doi:10.3390/molecules23020311. http://www.mdpi.com/1420-3049/23/2/311.
Lee, S.; Trinh, T.H.T.; Yoo, M.; Shin, J.; Lee, H.; Kim, J. (2019). ”Self-Assembling Peptides and Their Application in the Treatment of Diseases”. International Journal of Molecular Sciences 20 (23): sid. 5850. doi:10.3390/ijms20235850. https://www.mdpi.com/1422-0067/20/23/5850.
Bahar, A.A.; Ren, D. (2013). ”Antimicrobial Peptides”. Pharmaceuticals 6 (12): sid. 1543–1575. doi:10.3390/ph6121543. https://www.mdpi.com/1424-8247/6/12/1543.

nature.com

Zasloff, M. (2002). ”Antimicrobial peptides of multicellular organisms”. Nature 415 (6870): sid. 389–395. doi:10.1038/415389a. https://www.nature.com/articles/415389a.

nih.gov

ncbi.nlm.nih.gov

Boto, A.; Pérez de la Lastra, J.M.; González, C.C. (2018). ”The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs”. Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry 23 (2). doi:10.3390/molecules23020311. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017364/.

oup.com

academic.oup.com

Pachón-Ibáñez, M.E.; Smani, Y.; Pachón, J.; Sánchez-Céspedes, J. (2017). ”Perspectives for clinical use of engineered human host defense antimicrobial peptides”. FEMS Microbiology Reviews 41 (3): sid. 323–342. doi:10.1093/femsre/fux012. https://academic.oup.com/femsre/article/41/3/323/3830264.

royalsocietypublishing.org

Joo, H.S.; Fu, C.I.; Otto, M. (2016). ”Bacterial strategies of resistance to antimicrobial peptides”. Philosophical Transactions of the Royal Society B: Biological Sciences 371 (1695): sid. 20150292. doi:10.1098/rstb.2015.0292. https://royalsocietypublishing.org/doi/10.1098/rstb.2015.0292.
Habets, M.G.; Brockhurst, M.A. (2012). ”Therapeutic antimicrobial peptides may compromise natural immunity”. Biology Letters 8 (3): sid. 416–418. doi:10.1098/rsbl.2011.1203. https://royalsocietypublishing.org/doi/10.1098/rsbl.2011.1203.

sciencedirect.com

Reddy, K.; Yedery, R.; Aranha, C. (2004). ”Antimicrobial peptides: premises and promises”. International Journal of Antimicrobial Agents 24 (6): sid. 536–547. doi:10.1016/j.ijantimicag.2004.09.005. http://www.sciencedirect.com/science/article/pii/S092485790400322X.
Zhu, S. (2008). ”Discovery of six families of fungal defensin-like peptides provides insights into origin and evolution of the CSαβ defensins”. Molecular Immunology 45 (3): sid. 828–838. doi:10.1016/j.molimm.2007.06.354. http://www.sciencedirect.com/science/article/pii/S016158900700418X.
Chung, P.Y.; Khanum, R. (2017). ”Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria”. Journal of Microbiology, Immunology and Infection 50 (4): sid. 405–410. doi:10.1016/j.jmii.2016.12.005. http://www.sciencedirect.com/science/article/pii/S1684118217300804.
Chung, P.Y.; Khanum, R. (2017). ”Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria”. Journal of Microbiology, Immunology and Infection 50 (4): sid. 405–410. doi:10.1016/j.jmii.2016.12.005. http://www.sciencedirect.com/science/article/pii/S1684118217300804.
”Antimicrobial peptide mimics for improved therapeutic properties” (på engelska). Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (8): sid. 1582–1592. 2009-08-01. doi:10.1016/j.bbamem.2008.10.020. ISSN 0005-2736. https://www.sciencedirect.com/science/article/pii/S0005273608003416. Läst 25 november 2020.
Groisman, E.A. (1994). ”How bacteria resist killing by host-defense peptides”. Trends in Microbiology 2 (11): sid. 444–449. doi:10.1016/0966-842X(94)90802-8. http://www.sciencedirect.com/science/article/pii/0966842X94908028.

springer.com

link.springer.com

Mangoni, M.L. (2011). ”Host-defense peptides: from biology to therapeutic strategies”. Cellular and Molecular Life Sciences 68 (13): sid. 2157–2159. doi:10.1007/s00018-011-0709-3. http://link.springer.com/10.1007/s00018-011-0709-3.

tandfonline.com

Malmsten, M. (2014). ”Antimicrobial peptides”. Upsala Journal of Medical Sciences 119 (2): sid. 199–204. doi:10.3109/03009734.2014.899278. http://www.tandfonline.com/doi/full/10.3109/03009734.2014.899278.
Malmsten, M. (2014). ”Antimicrobial peptides”. Upsala Journal of Medical Sciences 119 (2): sid. 199–204. doi:10.3109/03009734.2014.899278. http://www.tandfonline.com/doi/full/10.3109/03009734.2014.899278.

web.archive.org

Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Albertí, S.; Bengoechea, J.A. (2004). ”Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides”. Infection and Immunity 72 (12): sid. 7107–7114. doi:10.1128/IAI.72.12.7107-7114.2004. Arkiverad från originalet den 21 juli 2020. https://web.archive.org/web/20200721224919/https://iai.asm.org/content/72/12/7107. Läst 4 maj 2020.

wiley.com

onlinelibrary.wiley.com

Bastos, P.; Trindade, F.; Costa, J.; Ferreira, R.; Vitorino, R. (2018). ”Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era”. Medicinal Research Reviews 38 (1): sid. 101–146. doi:10.1002/med.21435. https://onlinelibrary.wiley.com/doi/abs/10.1002/med.21435.

worldcat.org

”Antimicrobial peptide mimics for improved therapeutic properties” (på engelska). Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (8): sid. 1582–1592. 2009-08-01. doi:10.1016/j.bbamem.2008.10.020. ISSN 0005-2736. https://www.sciencedirect.com/science/article/pii/S0005273608003416. Läst 25 november 2020.